Instructions for Corilip (Riboflavin, Cocarboxylase, Thioctic acid)
Release form
Rectal suppositories
Description:
Rectal suppositories are a yellow-coloured product with an orange-yellow, torpedo-like appearance.
1 sp.
cocarboxylase hydrochloride 25 mg
riboflavin 2 mg
α-lipoic acid 12 mg
Auxiliary substances: Fat is solid (fatty acid glycerides) - 911 mg.
5 pcs. - packages of box contour (2) - cardboard packs.
ATC codes
A11EX Group B vitamins in combination with other drugs Riboflavin
Clinical-pharmacological groups / Group affiliation
Preparation having a general strengthening effect
Active substance
riboflavin
α-lipoic acid
cocarboxylase hydrochloride
Pharmacotherapy group Corilip
Metabolic agent
Storage Conditions
The drug Riboflavin should be stored in a place inaccessible to children, protected from light at a temperature not higher than 9 ° C.
Best before date
Shelf life is 2 years.
Testimony Corilip
As a monotherapy or as a supplement to the base therapy for various pathological conditions in children, including:
chronic tissue hypoxia;
reduced immunity;
bacterial and viral infections;
chronic somatic diseases;
chronic intoxication;
After suffering from serious diseases;
eating disorders (hypotrophy).
Periods of intense growth and the formation of new functions in the child, with intensive physical and mental strain, under stress situations.
As a general strengthening tool for the prevention of infectious diseases during the epidemic.
Method of use, course and dosage Corilip:
The preparation is used rectally. Once released from the packaging, the suppository should be introduced into the back passage (after preliminary emptying the intestines).
Infants and infants are given 1/2 suppository/day; Children aged 1 to 6 years) - 1 suppository/day each; Children aged 6 to 14 years - 1-2 suppositories/day.
Duration of treatment course - 10 days. The total duration of treatment is 3-4 courses with an interval of 20 days (3-4 months).
Use in children Corilip
The drug Riboflavin is intended for use in children.
Nosology (ICD codes)
P92.3
Underfeeding of the newborn
Z54
State of recovery
Z73.0
overwork
Z73.3
Stressful conditions not classified in other headings (physical and mental stress)
Pharmacological effect Corilip:
A drug Cocarboxylase with a general strengthening effect. A combined preparation, the action of which is determined by the effects of its constituent vitamins and coenzymes, as well as by the synergism of action.
Cocarboxylase hydrochloride (coenzyme) catalyzes carboxylation and decarboxylation of α-keto acids, participates in carbohydrate exchange processes, indirectly promotes the synthesis of nucleic acids, proteins, lipids through participation in the pentose cycle. Activates tissue exchange. The drug Cocarboxylase is used for correction of metabolic acidosis, cellular hypoxia, other metabolic disorders, liver failure, kidney failure, cardiovascular system, chronic intoxication.
Riboflavin (vitamin B2) as a coenzyme of flavinproteins is involved in the regulation of oxidation-reduction reactions, as well as in the processes of carbohydrate, protein and fat exchange; it plays an important role in the synthesis of hemoglobin and the maintenance of normal eye function, mucous membranes and skin.
Lipoic acid is involved in oxidative decarboxylation of pyruvic acid and α-keto acids, in regulating lipid and carbohydrate metabolism, plays an important role in the formation of energy in the body. Lipoic acid has hepatoprotective effect, improves detoxification function of the liver, protects against exposure to exo- and endotoxins.
Corilip improves tissue exchange in various physiological and pathological conditions requiring correction by cofactors and substrates.